News tagged with double blind study


Adalimumab is a promising therapy for children with Crohn's disease

Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the ...

Diseases, Conditions, Syndromes created Aug 06, 2012 | popularity not rated yet | comments 0